INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
Provided By PR Newswire
Last update: Jun 18, 2025
NEW YORK, June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.com20.08
-0.69 (-3.32%)
Find more stocks in the Stock Screener
SRPT Latest News and Analysis
6 days ago - ChartmillMarket Monitor News June 17 (ROKU, Advanced Micro Devices UP - Sarepta Therapeutics DOWN)Markets rebound on hopes of Iran de-escalation; oil drops, Roku surges on Amazon deal, Fed decision looms.
7 days ago - ChartmillMonday's session: top gainers and losersLooking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
7 days ago - ChartmillTop movers in Monday's sessionCurious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
7 days ago - ChartmillThese stocks are gapping in today's sessionThe session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
7 days ago - ChartmillMonday's pre-market session: top gainers and losersThe US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
